237 related articles for article (PubMed ID: 31904920)
1. Elucidating the Drug Release from Metal-Organic Framework Nanocomposites via In Situ Synchrotron Microspectroscopy and Theoretical Modeling.
Souza BE; Donà L; Titov K; Bruzzese P; Zeng Z; Zhang Y; Babal AS; Möslein AF; Frogley MD; Wolna M; Cinque G; Civalleri B; Tan JC
ACS Appl Mater Interfaces; 2020 Jan; 12(4):5147-5156. PubMed ID: 31904920
[TBL] [Abstract][Full Text] [Related]
2. Guest-host interactions of nanoconfined anti-cancer drug in metal-organic framework exposed by terahertz dynamics.
Souza BE; Rudić S; Titov K; Babal AS; Taylor JD; Tan JC
Chem Commun (Camb); 2019 Mar; 55(27):3868-3871. PubMed ID: 30801075
[TBL] [Abstract][Full Text] [Related]
3. Carboxymethylcellulose-coated 5-fluorouracil@MOF-5 nano-hybrid as a bio-nanocomposite carrier for the anticancer oral delivery.
Javanbakht S; Hemmati A; Namazi H; Heydari A
Int J Biol Macromol; 2020 Jul; 155():876-882. PubMed ID: 31805324
[TBL] [Abstract][Full Text] [Related]
4. Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery.
Dong H; Yang GX; Zhang X; Meng XB; Sheng JL; Sun XJ; Feng YJ; Zhang FM
Chemistry; 2018 Nov; 24(64):17148-17154. PubMed ID: 30125400
[TBL] [Abstract][Full Text] [Related]
5. Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.
Cui R; Zhao P; Yan Y; Bao G; Damirin A; Liu Z
Inorg Chem; 2021 Feb; 60(3):1664-1671. PubMed ID: 33434431
[TBL] [Abstract][Full Text] [Related]
6. A Luminescent Mg-Metal-Organic Framework for Sustained Release of 5-Fluorouracil: Appropriate Host-Guest Interaction and Satisfied Acid-Base Resistance.
Hu Z; Qiao C; Xia Z; Li F; Han J; Wei Q; Yang Q; Xie G; Chen S; Gao S
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14914-14923. PubMed ID: 32105065
[TBL] [Abstract][Full Text] [Related]
7. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
[TBL] [Abstract][Full Text] [Related]
8. MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics.
Gandara-Loe J; Souza BE; Missyul A; Giraldo G; Tan JC; Silvestre-Albero J
ACS Appl Mater Interfaces; 2020 Jul; 12(27):30189-30197. PubMed ID: 32530261
[TBL] [Abstract][Full Text] [Related]
9. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
10. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system.
Javanbakht S; Pooresmaeil M; Namazi H
Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803
[TBL] [Abstract][Full Text] [Related]
11. Carboxymethylcellulose capsulated Cu-based metal-organic framework-drug nanohybrid as a pH-sensitive nanocomposite for ibuprofen oral delivery.
Javanbakht S; Pooresmaeil M; Hashemi H; Namazi H
Int J Biol Macromol; 2018 Nov; 119():588-596. PubMed ID: 30071223
[TBL] [Abstract][Full Text] [Related]
12. Polymer/Metal Organic Framework (MOF) Nanocomposites for Biomedical Applications.
Giliopoulos D; Zamboulis A; Giannakoudakis D; Bikiaris D; Triantafyllidis K
Molecules; 2020 Jan; 25(1):. PubMed ID: 31906398
[TBL] [Abstract][Full Text] [Related]
13. A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy.
Jia Q; Li Z; Guo C; Huang X; Song Y; Zhou N; Wang M; Zhang Z; He L; Du M
Nanoscale; 2019 Nov; 11(43):20956-20967. PubMed ID: 31660562
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.
Chen G; Luo J; Cai M; Qin L; Wang Y; Gao L; Huang P; Yu Y; Ding Y; Dong X; Yin X; Ni J
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527488
[TBL] [Abstract][Full Text] [Related]
15. Photo-triggered release of 5-fluorouracil from a MOF drug delivery vehicle.
Roth Stefaniak K; Epley CC; Novak JJ; McAndrew ML; Cornell HD; Zhu J; McDaniel DK; Davis JL; Allen IC; Morris AJ; Grove TZ
Chem Commun (Camb); 2018 Jul; 54(55):7617-7620. PubMed ID: 29926872
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
17. Hollow structural metal-organic frameworks exhibit high drug loading capacity, targeted delivery and magnetic resonance/optical multimodal imaging.
Gao X; Cui R; Song L; Liu Z
Dalton Trans; 2019 Nov; 48(46):17291-17297. PubMed ID: 31714562
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of functional hollow microspheres constructed from MOF shells: Promising drug delivery systems with high loading capacity and targeted transport.
Gao X; Hai X; Baigude H; Guan W; Liu Z
Sci Rep; 2016 Nov; 6():37705. PubMed ID: 27876876
[TBL] [Abstract][Full Text] [Related]
19. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
[TBL] [Abstract][Full Text] [Related]
20. Metal organic framework-based polymeric hydrogel: A promising drug delivery vehicle for the treatment of breast cancer.
Pandya I; Kumar S; Aswal VK; El Seoud O; Assiri MA; Malek N
Int J Pharm; 2024 Jun; 658():124206. PubMed ID: 38734276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
